Tobramycin-resistant small colony variant mutant of Salmonella enterica serovar Typhimurium shows collateral sensitivity to nitrofurantoin

References

• Gong B, Li H, Feng Y, et al. Prevalence, serotype distribution and antimicrobial resistance of non-typhoidal salmonella in hospitalized patients in conghua district of Guangzhou, China. Front Cell Infect Microbiol. 2022;12:805384. doi: 10.3389/fcimb.2022.805384
   PubMed Web of Science ®Google Scholar
• Beikzadeh B. Immunoinformatics design of multi-epitope vaccine using OmpA, OmpD and enterotoxin against non-typhoidal salmonellosis. BMC Bioinf. 2023;24(1):63. doi: 10.1186/s12859-023-05183-6
   PubMed Web of Science ®Google Scholar
• Schiller LR. A germy world—food-borne infections in 2009. Nat Rev Gastroenterol Hepatol. 2009;6(4):197–15. doi: 10.1038/nrgastro.2009.40
   PubMed Web of Science ®Google Scholar
• Ao TT, Feasey NA, Gordon MA, et al. Global burden of invasive nontyphoidal salmonella disease, 20101. Emerg Infect Dis. 2015;21(6):941–949. doi: 10.3201/eid2106.140999
   PubMed Web of Science ®Google Scholar
• Kurtz JR, Goggins JA, McLachlan JB. Salmonella infection: interplay between the bacteria and host immune system. Immunol Lett. 2017;190:42–50. doi: 10.1016/j.imlet.2017.07.006
   PubMed Web of Science ®Google Scholar
• Martínez MC, Retamal P, Rojas-Aedo JF, et al. Multidrug-resistant outbreak-associated salmonella strains in irrigation water from the metropolitan region, Chile. Zoonoses Public Health. 2017;64(4):299–304. doi: 10.1111/zph.12311
   PubMed Web of Science ®Google Scholar
• Folster JP, Grass JE, Bicknese A, et al. Characterization of resistance genes and plasmids from outbreaks and illness clusters caused by salmonella resistant to ceftriaxone in the United States, 2011–2012. Microb Drug Resist. 2017;23(2):188–193. doi: 10.1089/mdr.2016.0080
   PubMed Web of Science ®Google Scholar
• Alt K, Simon S, Helmeke C, et al. Outbreak of uncommon O4 non-agglutinating salmonella typhimurium linked to minced pork, saxony-anhalt, Germany, January to April 2013. PLOS ONE. 2015;10(6):e0128349. doi: 10.1371/journal.pone.0128349
   PubMed Web of Science ®Google Scholar
• Xiang Y, Li F, Dong N, et al. Investigation of a salmonellosis outbreak caused by multidrug resistant salmonella typhimurium in China. Front Microbiol. 2020;11:801. doi: 10.3389/fmicb.2020.00801
   PubMed Web of Science ®Google Scholar
• Zafar S, Ajab H, Mughal ZU, et al. Prediction and evaluation of multi epitope based sub-unit vaccine against salmonella typhimurium. Saudi J Biol Sci. 2022;29(2):1092–1099. doi: 10.1016/j.sjbs.2021.09.061
   PubMed Web of Science ®Google Scholar
• Besse A, Groleau MC, Déziel E, et al. Emergence of small colony variants is an adaptive strategy used by pseudomonas aeruginosa to mitigate the effects of redox imbalance. mSphere. 2023;8(2):e0005723. doi: 10.1128/msphere.00057-23
   PubMed Web of Science ®Google Scholar
• Richter K, Thomas N, Zhang G, et al. Deferiprone and Gallium-Protoporphyrin have the capacity to potentiate the activity of antibiotics in staphylococcus aureus small colony variants. Front Cell Infect Microbiol. 2017;7:280. doi: 10.3389/fcimb.2017.00280
   PubMed Web of Science ®Google Scholar
• Proctor RA, von Eiff C, Kahl BC, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol. 2006;4(4):295–305. doi: 10.1038/nrmicro1384
   PubMed Web of Science ®Google Scholar
• Cano DA, Pucciarelli MG, Martínez-Moya M, et al. Selection of small-colony variants of salmonella enterica serovar typhimurium in nonphagocytic eucaryotic cells. Infect Immun. 2003;71(7):3690–3698. doi: 10.1128/IAI.71.7.3690-3698.2003
   PubMed Web of Science ®Google Scholar
• Li W, Li Y, Wu Y, et al. Phenotypic and genetic changes in the life cycle of small colony variants of salmonella enterica serotype typhimurium induced by streptomycin. Ann Clin Microbiol Antimicrob. 2016;15(1):37. doi: 10.1186/s12941-016-0151-3
   PubMedGoogle Scholar
• Pränting M, Andersson DI. Escape from growth restriction in small colony variants of salmonella typhimurium by gene amplification and mutation. Mol Microbiol. 2011;79(2):305–315. doi: 10.1111/j.1365-2958.2010.07458.x
   PubMed Web of Science ®Google Scholar
• Pränting M, Andersson DI. Mechanisms and physiological effects of protamine resistance in salmonella enterica serovar typhimurium LT2. J Antimicrob Chemother. 2010;65(5):876–887. doi: 10.1093/jac/dkq059
   PubMed Web of Science ®Google Scholar
• Aurass P, Düvel J, Karste S, et al. glnA truncation in salmonella enterica results in a small colony variant phenotype, attenuated host cell entry, and reduced expression of flagellin and SPI-1-Associated effector genes. Appl Environ Microbiol. 2018;84(2):e01838–17. doi: 10.1128/AEM.01838-17
   PubMed Web of Science ®Google Scholar
• Tueffers L, Barbosa C, Bobis I, et al. Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days. J Antimicrob Chemother. 2019;74(10):2916–2925. doi: 10.1093/jac/dkz297
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi: 10.1016/S1473-3099(15)00424-7
   PubMed Web of Science ®Google Scholar
• Bloemberg GV, Keller PM, Stucki D, et al. Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis. New Engl J Med. 2015;373(20):1986–1988. doi: 10.1056/NEJMc1505196
   PubMed Web of Science ®Google Scholar
• Sanz-García F, Gil-Gil T, Laborda P, et al. Translating eco-evolutionary biology into therapy to tackle antibiotic resistance. Nat Rev Microbiol. 2023;21(10):671–685. doi: 10.1038/s41579-023-00902-5
   PubMed Web of Science ®Google Scholar
• Imamovic L, Sommer MO. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med. 2013;5(204):204ra132. doi: 10.1126/scitranslmed.3006609
   PubMed Web of Science ®Google Scholar
• Szybalski W, Bryson V. Genetic studies on microbial cross resistance to toxic agents I. J Bacteriol. 1952;64(4):489–499. doi: 10.1128/jb.64.4.489-499.1952
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang S, Chen W, et al. CRISPR-Cas9 and CRISPR-Assisted cytidine deaminase enable precise and efficient genome editing in Klebsiella pneumoniae. Appl Environ Microbiol. 2018;84(23):e01834–18. doi: 10.1128/AEM.01834-18
   PubMed Web of Science ®Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing. 31st ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2021.
   Google Scholar
• Weissman Z, Pinsky M, Donegan RK, et al. Using genetically encoded heme sensors to probe the mechanisms of heme uptake and homeostasis in Candida albicans. Cell Microbiol. 2021;23(2):e13282. doi: 10.1111/cmi.13282
   PubMed Web of Science ®Google Scholar
• Te Winkel JD, Gray DA, Seistrup KH, et al. Analysis of antimicrobial-triggered membrane depolarization using voltage sensitive dyes. Front Cell Dev Biol. 2016;4:29. doi: 10.3389/fcell.2016.00029
   PubMed Web of Science ®Google Scholar
• Bitoun JP, Liao S, Xie GG, et al. Deficiency of BrpB causes major defects in cell division, stress responses and biofilm formation by streptococcus mutans. Microbiol (Reading). 2014;160(1):67–78. doi: 10.1099/mic.0.072884-0
   PubMedGoogle Scholar
• Li Q, Chen S, Zhu K. Collateral sensitivity to pleuromutilins in vancomycin-resistant enterococcus faecium. Nat Commun. 2022;13(1):1888. doi: 10.1038/s41467-022-29493-0
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Zhou YF, Tao MT, He YZ, et al. In vivo bioluminescent monitoring of therapeutic efficacy and pharmacodynamic target assessment of antofloxacin against Escherichia coli in a neutropenic murine thigh infection model. Antimicrob Agents Chemother. 2018;62(1):e01281–17. doi: 10.1128/AAC.01281-17
   PubMed Web of Science ®Google Scholar
• Barthel M, Hapfelmeier S, Quintanilla-Martínez L, et al. Pretreatment of mice with streptomycin provides a salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71(5):2839–2858. doi: 10.1128/IAI.71.5.2839-2858.2003
   PubMed Web of Science ®Google Scholar
• Barthel A, Ursenbach A, Kaeuffer C, et al. Characteristics and treatment of gordonia spp bacteremia, France. Emerg Infect Dis. 2023;29(5):1025–1028. doi: 10.3201/eid2905.221901
   PubMed Web of Science ®Google Scholar
• Elliott T, Avissar YJ, Rhie GE, et al. Cloning and sequence of the salmonella typhimurium hemL gene and identification of the missing enzyme in hemL mutants as glutamate-1-semialdehyde aminotransferase. J Bacteriol. 1990;172(12):7071–7084. doi: 10.1128/jb.172.12.7071-7084.1990
   PubMed Web of Science ®Google Scholar
• Morales EH, Pinto CA, Luraschi R, et al. Accumulation of heme biosynthetic intermediates contributes to the antibacterial action of the metalloid tellurite. Nat Commun. 2017;8(1):15320. doi: 10.1038/ncomms15320
   PubMedGoogle Scholar
• Taber HW, Mueller JP, Miller PF, et al. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987;51(4):439–457. doi: 10.1128/mr.51.4.439-457.1987
   PubMedGoogle Scholar
• Xia Y, Wang D, Pan X, et al. TpiA is a key metabolic enzyme that affects virulence and resistance to aminoglycoside antibiotics through CrcZ in pseudomonas aeruginosa. MBio. 2020;11(1):e02079–19. doi: 10.1128/mBio.02079-19
   PubMed Web of Science ®Google Scholar
• Meylan S, Porter CBM, Yang JH, et al. Carbon sources tune antibiotic susceptibility in pseudomonas aeruginosa via tricarboxylic acid cycle control. Cell Chem Biol. 2017;24(2):195–206. doi: 10.1016/j.chembiol.2016.12.015
   PubMed Web of Science ®Google Scholar
• Liu Y, Tong Z, Shi J, et al. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine. Commun Biol. 2021;4:1328. doi: 10.1038/s42003-021-02854-z
   PubMed Web of Science ®Google Scholar
• Ren H, Zhong Z, Zhou S, et al. CpxA/R-Controlled nitroreductase expression as target for combinatorial therapy against uropathogens by promoting reactive oxygen species generation. Adv Sci. 2023;10(25):e2300938. doi: 10.1002/advs.202300938
   Web of Science ®Google Scholar
• Bryan LE, Kwan S. Aminoglycoside-resistant mutants of pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport. Antimicrob Agents Chemother. 1981;19(6):958–964. doi: 10.1128/AAC.19.6.958
   PubMed Web of Science ®Google Scholar
• Proctor RA, van Langevelde P, Kristjansson M, et al. Persistent and relapsing infections associated with small-colony variants of staphylococcus aureus. Clin Infect Dis. 1995;20:95–102. doi: 10.1093/clinids/20.1.95
   PubMed Web of Science ®Google Scholar
• Vulin C, Leimer N, Huemer M, et al. Prolonged bacterial lag time results in small colony variants that represent a sub-population of persisters. Nat Commun. 2018;9:4074. doi: 10.1038/s41467-018-06527-0
   PubMed Web of Science ®Google Scholar
• Zheng X, Fang R, Wang C, et al. Resistance profiles and biological characteristics of rifampicin-resistant staphylococcus aureus small-colony variants. Infect Drug Resist. 2021;14:1527–1536. doi: 10.2147/IDR.S301863
   PubMed Web of Science ®Google Scholar
• Noaman KA, Alharbi NS, Khaled JM, et al. The transmutation of Escherichia coli ATCC 25922 to small colony variants (SCVs) E. coli strain as a result of exposure to gentamicin. J Infect Public Health. 2023;16(11):1821–1829. doi: 10.1016/j.jiph.2023.08.024
   PubMed Web of Science ®Google Scholar
• Tuchscherr L, Löffler B, Proctor RA. Persistence of staphylococcus aureus: multiple metabolic pathways impact the expression of virulence factors in small-colony variants (SCVs). Front Microbiol. 2020;11:1028. doi: 10.3389/fmicb.2020.01028
   PubMed Web of Science ®Google Scholar
• Lozano C, Azcona-Gutiérrez JM, Van Bambeke F, et al. Great phenotypic and genetic variation among successive chronic pseudomonas aeruginosa from a cystic fibrosis patient. PLOS ONE. 2018;13(9):e0204167. doi: 10.1371/journal.pone.0204167
   PubMed Web of Science ®Google Scholar
• Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 2011;473(7346):216–220. doi: 10.1038/nature10069
   PubMed Web of Science ®Google Scholar
• Schneider M, Mühlemann K, Droz S, et al. Clinical characteristics associated with isolation of small-colony variants of staphylococcus aureus and pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 2008;46(5):1832–1834. doi: 10.1128/JCM.00361-08
   PubMed Web of Science ®Google Scholar
• Fino C, Vestergaard M, Ingmer H, et al. PasT of Escherichia coli sustains antibiotic tolerance and aerobic respiration as a bacterial homolog of mitochondrial Coq10. Microbiologyopen. 2020;9(8):e1064. doi: 10.1002/mbo3.1064
   PubMed Web of Science ®Google Scholar
• Nitzschke A, Bettenbrock K, Weiner JH. All three quinone species play distinct roles in ensuring optimal growth under aerobic and fermentative conditions in E. coli K12. PLOS ONE. 2018;13(4):e0194699. doi: 10.1371/journal.pone.0194699
   PubMed Web of Science ®Google Scholar
• Jastroch M, Divakaruni AS, Mookerjee S, et al. Mitochondrial proton and electron leaks. Essays Biochem. 2010;47:53–67. doi: 10.1042/bse0470053
   PubMed Web of Science ®Google Scholar
• Hernando-Amado S, Laborda P, Martínez JL. Tackling antibiotic resistance by inducing transient and robust collateral sensitivity. Nat Commun. 2023;14(1):1723. doi: 10.1038/s41467-023-37357-4
   PubMed Web of Science ®Google Scholar
• Thulin E, Sundqvist M, Andersson DI. Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli. Antimicrob Agents Chemother. 2015;59(3):1718–1727. doi: 10.1128/AAC.04819-14
   PubMed Web of Science ®Google Scholar
• McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994;33(Suppl A):23–30. doi: 10.1093/jac/33.suppl_A.23
   PubMedGoogle Scholar
• Roemhild R, Linkevicius M, Andersson DI, et al. Molecular mechanisms of collateral sensitivity to the antibiotic nitrofurantoin. PLOS Biol. 2020;18(1):e3000612. doi: 10.1371/journal.pbio.3000612
   PubMed Web of Science ®Google Scholar
• Zuma NH, Aucamp J, N’Da DD. An update on derivatisation and repurposing of clinical nitrofuran drugs. Eur J Pharm Sci. 2019;140:105092. doi: 10.1016/j.ejps.2019.105092
   PubMed Web of Science ®Google Scholar